help button home button Am J Pathol R & D Systems
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Muldoon, L. L.
Right arrow Articles by Weiss, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Muldoon, L. L.
Right arrow Articles by Weiss, D. L.

American Journal of Pathology, Vol 144, 1109-1118, Copyright © 1994 by American Society for Investigative Pathology


REGULAR ARTICLES

Characterization of the molecular defect in a feline model for type II GM2-gangliosidosis (Sandhoff disease)

LL Muldoon, EA Neuwelt, MA Pagel and DL Weiss
Department of Neurology, Oregon Health Sciences University, Portland 97201.

The Korat cat provides an animal model for type II GM2-gangliosidosis (Sandhoff disease) that may be suitable for tests of gene replacement therapy with the HEXB gene encoding the beta subunit of the beta- hexosaminidases. In the present report, we examined the brain and liver pathology of a typical Sandhoff-affected cat. We characterized the feline HEXB complementary DNA (cDNA) and determined the molecular defect in this feline model. cDNA libraries were produced from one normal and one affected animal, and cDNA clones homologous to human HEXB were sequenced. In the affected cDNA clone, the deletion of a cytosine residue at position +39 of the putative coding region results in a frame shift and a stop codon at base +191. This disease-related deletion was consistently detected by sequencing of cloned polymerase chain reaction amplified reverse transcribed messenger RNA from one more normal Korat and two additional affected animals. The defect was further demonstrated using single-strand conformational polymorphism analysis of the polymerase chain reaction products. In addition, alternative splicing of both normal and affected messenger RNAs was demonstrated. These results should facilitate the use of this animal model to assess gene therapy.


This article has been cited by other articles:


Home page
Genome ResHome page
J. U. Pontius, J. C. Mullikin, D. R. Smith, Agencourt Sequencing Team, K. Lindblad-Toh, S. Gnerre, M. Clamp, J. Chang, R. Stephens, B. Neelam, et al.
Initial sequence and comparative analysis of the cat genome
Genome Res., November 1, 2007; 17(11): 1675 - 1689.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. L. Mark, G. A. Wasney, T. J. S. Salo, A. R. Khan, Z. Cao, P. W. Robbins, M. N. G. James, and B. L. Triggs-Raine
Structural and Functional Characterization of Streptomyces plicatus beta -N-Acetylhexosaminidase by Comparative Molecular Modeling and Site-directed Mutagenesis
J. Biol. Chem., July 31, 1998; 273(31): 19618 - 19624.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 by the American Society for Investigative Pathology.